The Future of Supply Chains: Chris Andrassy on Using AI to Predict & Prevent Disruptions
A Less is More Strategy for Data Risk Mitigation
AGG Talks: Cross-Border Business Podcast - Episode 26: U.S. Enforcement Trends Targeting Foreign Pharmaceutical and Medical Device Manufacturers
Key Discovery Points: Even AI Experts Can Get Faked Out
PilieroMazza Annual Review: What DOJ’s 2024 FCA Report Means for Government Contractors
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 223: Cybersecurity and Privacy Risks with Healthcare Vendors with Brandon Robinson of Maynard Nexsen
Government Contracts and New Mandates Executive Orders and Cost Recovery Strategies Explained
Podcast: Are Legal Holds Protected by Privilege? Insights from the FTC's Battle with Amazon
Consumer Finance Monitor Podcast Episode: Regulating Bank Reputation Risk
4 Key Takeaways | AI in Precision Agriculture Legal Risks and Mitigation
The Duty to Cooperate Under a Liability Policy
On-Demand Webinar: Bring Predictability and Reduce the Spiraling Cost of Cyber Incident Response
Preparing for CMS Staffing Mandates — Assisted Living and the Law Podcast
Everyone Come to Play: Exploring FOCI Mitigation Instruments
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 211: Cybersecurity and Privacy Risks for the Healthcare Industry with Brandon Robinson of Maynard Nexsen
Fraud Prevention Techniques for Nonprofit Organizations - Part 3
Steps Your Nonprofit Can Take to Mitigate Fraud Risks - Part 2
Why Retailers and Merchants Should Pay Attention to the CFPB - The Consumer Finance Podcast
The Justice Insiders Podcast - The Ever-Expanding Net: Corporate Compliance in an Era of Increasing Trade Sanctions and Restrictions
Fraud Risks at Nonprofit Organizations - Part 1
AGG partner and Life Science team member, Allison Raley, will present a complimentary webinar examining how life sciences companies can overcome challenges in the face of U.S. tariffs. As international trade tensions persist...more
Our FDA Compliance & Enforcement Team reviews how the Food and Drug Administration’s first guidance on nitrosamine impurities shows what the FDA has learned about the sources of such impurities and what manufacturers can do...more
Report on Supply Chain Compliance 3, no. 4 (February 20, 2020) - The coronavirus that has, at the time of writing, infected more than 40,000 people around the world and killed more than 1,000, is also ravaging...more
As competition intensifies and auto manufacturers and distributors look for new ways to realize value from their brands, they and their counsel would do well to familiarize themselves with the Federal Trade Commission’s (FTC)...more
During a year in which legislative activity was restrained by a variety of factors, most notably the Senate’s inability to maintain a consistent majority, the New York State Legislature nonetheless still passed 641 bills,...more
Cybersecurity risks to the health and medical device sector continue to be front and center both in Congress and the executive branch, with increasing risks coming from nation states, nonstate actors and other attackers. The...more
Each year, food, beverage and agribusiness companies pay millions of dollars in settlements, penalties and judgments to consumers allegedly harmed through the sale, advertisement and manufacture of their products. The legal...more
On July 25 and 26, 2016, industry stakeholders assembled in Arlington, Virginia, to participate in the Medical Device Cybersecurity Risk Mitigation Conference sponsored by Q1 Productions. The conference focused on the...more
Manufacturers of components incorporated into consumer products increasingly find themselves involved in product liability class action lawsuits. Manufacturers can be drawn into these types of lawsuits when their own customer...more
Every day companies deal with an ongoing safety analysis of their own products. These Safety Teams are routinely interdepartmental. The Safety Teams must consider design changes, manufacturing issues, potential recalls,...more
The FDA issued a new draft guidance on July 15th which further explains how the FDA currently fails to protect consumers of medical devices and pharmaceutical drugs. It is important to remember that these sort of FDA-issued...more